FDA Inspection 1020123 — OneBlood Inc
The FDA completed an inspection of OneBlood Inc on June 14, 2017 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tallahassee, FL (United States)